Information Journal Paper
APA:
Copy. (2017). Rituximab as firstline treatment for acquired thrombotic thrombocytopenic purpura. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 45(3), 1253-1260. SID. https://sid.ir/paper/737605/en
Vancouver:
Copy. Rituximab as firstline treatment for acquired thrombotic thrombocytopenic purpura. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH[Internet]. 2017;45(3):1253-1260. Available from: https://sid.ir/paper/737605/en
IEEE:
Copy, “Rituximab as firstline treatment for acquired thrombotic thrombocytopenic purpura,” JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol. 45, no. 3, pp. 1253–1260, 2017, [Online]. Available: https://sid.ir/paper/737605/en